Noonan Spectrum Disorders/RASopathies Panel
Use
This test is aimed at individuals who exhibit relevant features or have a clinical or suspected diagnosis of Noonan syndrome or related RASopathies. It is also suitable for individuals who have received negative results from previous limited RASopathy gene testing.
Special Instructions
Add exome-wide CNV analysis for $250 with PGxome-based or custom panels. STAT Testing available with a 25% surcharge if delivered beyond 16 days. Refer to the test requisition form for detailed order options and instructions.
Limitations
The tests developed and validated by PreventionGenetics have not been cleared or approved by the US Food and Drug Administration. It is important to consider these limitations when interpreting the test results. Please consult with a healthcare provider for further guidance.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided